We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

195 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $668K | Put options by funds: $339K

6% less funds holding

Funds holding: 207 → 195 (-12)

8.81% less ownership

Funds ownership: 61.84% → 53.03% (-8.8%)

21% less capital invested

Capital invested by funds: $64.8M → $51M (-$13.8M)

28% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 61

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
195
Holders Change
-12
Holders Change %
-5.8%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
44
Reduced
61
Closed
34
Calls
$668K
Puts
$339K
Net Calls
+$329K
Net Calls Change
+$321K

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$2.1M
2
Morgan Stanley
Morgan Stanley
New York
+$1.65M
3
Bank of America
Bank of America
North Carolina
+$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$946K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$822K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.62M
2
Goldman Sachs
Goldman Sachs
New York
-$1.79M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.65M
4
MAM
Monaco Asset Management
Monaco
-$1.36M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
OCM
151
Orion Capital Management
California
$348 – – –
PS
152
Principal Securities
Iowa
$311 – – –
LFG
153
Larson Financial Group
Missouri
$283 – – –
HPC
154
HM Payson & Co
Maine
$244 – – –
TSMHT
155
Thurston Springer Miller Herd & Titak
Indiana
$237 – – –
WIM
156
Westside Investment Management
California
$232 -$1.99K -1,350 -87%
RP
157
Raelipskie Partnership
Ontario, Canada
$232 – – –
SSG
158
Summit Securities Group
New York
$206 +$262 +178 New
GIA
159
GHP Investment Advisors
Colorado
$191 +$241 +164 New
AF
160
Advisornet Financial
Minnesota
$174 – – –
AG
161
AmeriFlex Group
Nevada
$174 – – –
SIS
162
Sound Income Strategies
Florida
$174 – – –
RIL
163
Rothschild Investment LLC
Illinois
$174 +$29 +20 +15%
AAP
164
Arax Advisory Partners
Colorado
$174 +$221 +150 New
GWSA
165
Global Wealth Strategies & Associates
Colorado
$145 +$184 +125 New
CA
166
CoreCap Advisors
Michigan
$133 – – –
FFA
167
Farther Finance Advisors
California
$120 -$177 -120 -53%
PMFA
168
Plante Moran Financial Advisors
Michigan
$116 – – –
VCM
169
Versant Capital Management
Arizona
$116 – – –
SW
170
SVB Wealth
Massachusetts
$110 +$140 +95 New
Comerica Bank
171
Comerica Bank
Texas
$109 -$1.52K -1,036 -92%
CW
172
Curio Wealth
Maryland
$98 +$1 +1 New
KFI
173
Key Financial Inc
Pennsylvania
$87 – – –
MBFW
174
Morton Brown Family Wealth
Pennsylvania
$75 – – –
TC
175
Truvestments Capital
Florida
$71 – – –
5 6
7
8 9

EDIT Hedge Fund Activity: Q1 2025 in Review

195 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2025, worth a combined $51M — down 21% from $64.8M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of EDIT and 23 opened new positions — a net loss of 11 holders — while 61 trimmed existing stakes and 44 added.

The largest buyer was UBS AM, adding an estimated $2.1M. The largest seller was Millennium Management, cutting an estimated $3.62M.

  • 195 institutional investors held Editas Medicine (EDIT) as of Q1 2025, down from 207 in Q4 2024.
  • Funds reported $51M of Editas Medicine stock for Q1 2025, down 21% quarter-over-quarter.
  • 23 funds opened new Editas Medicine positions in Q1 2025 and 34 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q1 2025 was UBS AM, an estimated $2.1M added.
  • The largest Editas Medicine seller in Q1 2025 was Millennium Management, an estimated $3.62M sold.

Based on aggregated 13F filings for Q1 2025.